Abstract: A device includes an angiography module, a phototherapy module, a carrier including an optical filter and accommodating the angiography module and the phototherapy module, and a control unit controlling operation of the angiography module and the phototherapy module. The angiography module includes infrared LEDs emitting infrared light through the optical filter to irradiate a limb of a subject, and an infrared sensor sensing a part of the infrared light reflected off the limb to generate a result, based on which the control unit generates an angiogram. The phototherapy module emits infrared light through the optical filter to irradiate the limb for phototherapy.

Abstract: A surgical instrument is disclosed including an end effector operable to treat tissue, a shaft extending proximally from the end effector, and a housing assembly extending proximally from the shaft. The housing assembly includes a radio-frequency identification (RFID) scanner and a motor-assembly compartment including a motor assembly interchangeably retained by the motor-assembly compartment in an assembled configuration. The motor assembly is movable relative to the motor-assembly compartment between the assembled configuration and an unassembled configuration. The motor assembly includes a motor configured to drive the end effector to treat the tissue and an RFID tag detectable by the RFID scanner in the assembled configuration. The RFID tag stores motor-assembly information.

Abstract: An implant system for photodynamic therapy with a light source for radiating light which is implantable in a resection cavity, and with an autonomous control unit which is connectable via a supply line to the light source.

Abstract: This invention relates to a therapeutic device for treating a human or animal body, comprising an array of infrared-emitting elements disposed on or within a flexible substrate and attached to the body part to be treated using an attachment means, said array comprising a first plurality of infrared-emitting ceramic elements having a specific spectral luminance covering at least a part of the 3-7 micrometer wavelength spectrum and having a peak wavelength between 3 and 7 micrometers, and a second plurality of infrared-emitting ceramic elements having a specific spectral luminance covering at least a part of the 7-14 micrometer wavelength spectrum and having a peak wavelength between 7 and 14, that provides an effective means to healing the body.

Abstract: A catheter system for treating a treatment site within or adjacent to a vessel wall or a heart valve, includes a light source, a balloon, a light guide and an optical analyzer assembly. The light source generates first light energy. The balloon is positionable substantially adjacent to the treatment site. The balloon has a balloon wall that defines a balloon interior that receives a balloon fluid. The light guide receives the first light energy and guides the first light energy in a first direction from a guide proximal end toward a guide distal end positioned within the balloon interior. The optical analyzer assembly optically analyzes a second light energy from the light guide that moves in a second direction that is opposite the first direction. The optical analyzer assembly includes a safety shutdown system to inhibit the first light energy from being received by the guide proximal end of the light guide.

Abstract: A method for optogenetics experiments, based on wavefront shaping and including: calculating the transmission matrix between an input end and an output end of the multimode fiber under a fixed shape; implanting the output end into an intracranial space of an experimental subject; and performing wavefront compensation to a light to be input into the input end, according to the spatial position of the optical stimulation and the transmission matrix of the multimode fiber, to form a compensated expanded light, and inputting the compensated expanded light from the input end into the multimode fiber, such that the compensated expanded light, after being transmitted by the multimode fiber to the output end and output from the output end, is capable of focusing at the spatial position of the optical stimulation.

Abstract: A photoacoustic catheter can include an elongate shaft and a first photoacoustic transducer. The elongate shaft can extend from a proximal region to a distal region and can include a first light guide that is in optical communication with a light source. The first photoacoustic transducer can be disposed within the distal region of the elongate shaft and can be in optical communication with the first light guide. The first photoacoustic transducer can impart acoustic pressure waves upon a calcified lesion to induce fractures. The first photoacoustic transducer can include a light-absorbing material and a thermal expansion material that can be in contact with one another.

Abstract: An illumination apparatus is disclosed, comprising: a first light source having a first spectral light distribution with a first light intensity peak about a first peak wavelength, and a second light source having a second spectral light distribution with a second light intensity peak about a second peak wavelength being different from the first peak wavelength, a third light source having a third spectral light distribution with a main light intensity peak about a third peak wavelength being different from the first peak wavelength and from the second peak wavelength, wherein the illumination apparatus is configured to provide adjustment of light intensity of the first light source and of light of the second light source, wherein the illumination apparatus provides an adjustment of light intensity of the third light source to compensate for the adjusting of the relative light intensity between the first light source and the second light source.

Abstract: A beauty instrument with mask includes a flexible mask and a controller. The flexible mask includes a first flexible layer, a second flexible layer, a plurality of functional layers located between the first flexible layer and the second flexible layer, and a plurality of electrodes electrically connected with the plurality of functional layers. The functional layer includes a graphene layer. The flexible mask is electrically coupled with the controller via the plurality of electrodes.

Abstract: A catheter system for treating a treatment site within or adjacent to a vessel wall within a body of a patient includes an energy source, a balloon, and an energy guide. The energy source generates energy. The balloon includes a balloon wall that defines a balloon interior. The balloon is configured to retain a balloon fluid within the balloon interior. The balloon is selectively inflatable with the balloon fluid to expand to an inflated state, wherein when the balloon is in the inflated state the balloon wall is configured to be positioned substantially adjacent to the treatment site. The balloon further includes a balloon central axis that extends through a geometric center of the balloon when the balloon is in the inflated state. The energy guide selectively receives energy from the energy source and guides the energy from the energy source into the balloon interior. The energy guide including a guide distal end that is positioned on the balloon central axis when the balloon is in the inflated state.

Abstract: A catheter for debulking of an undesired deposit from an inner surface of at least one of a blood vessel wall and a stent located in a blood vessel, the catheter having a tip section comprising: circumferentially-directed laser optics; and a circular-action cutter, wherein said circumferentially-directed laser optics is configured to transmit laser radiation for modifying an area of the undesired deposit thereby preparing said area for penetration of said cutter, wherein said cutter is configured to cut through said modified area and thereby debulk at least a part of the undesired deposit. In addition, a catheter for pacemaker and ICD (Implantable Cardioverter Defibrillator) lead extraction is disclosed.

Abstract: An optical stimulation system includes a light source; an optical lead coupled, or coupleable, to the light source; at least one of a calibration table or a calibration formula, generated by a calibration procedure specifically using the light source and the optical lead of the optical stimulation system; and a control unit coupled, or coupleable, to the light source. The control module includes a memory to store the at least one of the calibration table or the calibration formula, and a processor coupled to the memory and configured for receiving a target light output level, using the at least one of the calibration table or the calibration formula to determine at least one operational parameter for generating the target light output level, and directing the light source, using the at least one operational parameter, to generate light at the target light output level.

Abstract: A neural sensing system includes an interrogator that includes an optical head. The optical head is configured to transmit a light signal. The neural sensing system also includes a microprobe configured to contact tissue. The microprobe includes a transducer configured to receive the light signal and modulate the light signal with neural signal information sensed from the tissue. The microprobe also includes a retroreflector configured to reflect the modulated light signal back to the optical head of the interrogator.

Abstract: A subject's Default Mode Network is accessed through corresponding measurements of the Micro-Coherence Oximetry Network Strength (MCO-S). An associated MCO-S system (100) includes a wearable (102), a user device (112) and a processing platform (123). The wearable (102) collects subject information sufficient to enable monitoring and optimization of the subject's Default Mode Network include sensors such as pulse oximetry instrumentation and EEG electrodes to obtain brainwave data, oxygen saturation data, heart rate variability data, and galvanic skin conductance data. Information from the sensors may be communicated to a user device (112), such as a cell phone or VR headset. The user device (112) communicates with a remote processing platform (123) that may execute artificial intelligence functionality and other logic in connection with assessing the patient's micro-coherence network strength and optimizing behavior modification protocols in relation to attributes and objectives of the subject.

Abstract: A method for using beauty instrument with mask is provided. The method comprises providing a beauty instrument with mask comprising a flexible mask and a controller, applying the flexible mask of on a user's face, and turning on the controller and selecting a function button on the controller, inputting a current to a plurality of functional layers in the flexible mask, and stimulating face skin with the current.

Abstract: An electrode multiplexing physiological parameter monitoring ring, comprising a built-in power supply (2), a microprocessor module (1), an electrocardiogram monitoring analog front end (3), a skin conductance monitoring module (4), a first electrode (6), and a second electrode (7). The microprocessor module (1) is connected to the electrocardiogram monitoring analog front end (3) and the skin conductance monitoring module (4). The first electrode (6) and the second electrode (7) are connected to the electrocardiogram monitoring analog front end (3), and the electrocardiogram monitoring analog front end (3) processes electrocardiogram signals collected by the first electrode (6) and the second electrode (7). The first electrode (6) and the second electrode (7) are further connected to the skin conductance monitoring module (4), and the skin conductance monitoring module (4) processes skin impedance signals collected by the first electrode (6) and the second electrode (7).

Abstract: The process for classifying anesthetic depth includes: collecting of biological signals, conditioning of said signals, monitoring of activity of the central and autonomic systems, measurement of indexes and classification of patterns in anesthetic depth. The activity includes: i) Awake: Vigil—Ak. and recovery of verbal response—Rc. ii) Light Anesthesia: Light induction anesthesia—Li. Light recovery—Lr, Light dose, increase in drugs or patient movement (La), iii) General anesthesia: General anesthesia—Ga, one minute after the start of the surgery, and iv) Deep anesthesia: identification of the EEG burst-suppression pattern (BSP) associated with deep anesthesia.

Abstract: A modular wearable health monitor having a substantially flexible attachment means connected to a housing comprising a power source and at least one processor through a relatively rigid and narrow spine disposed substantially centrally thereon having a variety of clinical and non-clinical uses that provides more comfortable and durable attachment of biometric sensors to a user by allowing the attachment means to contour to the user's body without the housing also being forced to do so along its entire width.

Abstract: A light adjustable lens illumination system comprises an illumination source, for generating a light beam; a light delivery system, for projecting the light beam onto a Light Adjustable Lens (LAL), implanted into an eye, wherein a fraction of the light beam propagates past the LAL to a retina of the eye; and a protective beam-shaper, for shaping the light beam to have an intensity pattern with a relative central intensity reduction that varies along an axis; wherein the relative central intensity reduction at the retina is greater than the relative central intensity reduction at a LAL plane.

Abstract: A circadian rhythm entrainment platform can use medication circadian profiles that include mappings of medications to circadian rhythm disruptions and can make conversions of such circadian rhythm disruptions to administrations of light therapy to adjust for the disruptions. The circadian rhythm entrainment platform can specify how to entrain a patient's circadian rhythm using light therapy to compensate for or anticipate side effects of medications and for optimizing medication schedules for a patient's circadian rhythm so as to minimize side effects and increase medication effectiveness. The circadian rhythm entrainment platform can also gather information on the effects of medications on circadian rhythms and interact with patients, medical providers, and other providers in relation to light therapy.